Orphan 3 star Isabelle Fuhrman has shared some exciting new details about the upcoming horror sequel. The film follows 2022’s Orphan: First Kill, a prequel to 2009’s Orphan. In both titles, Fuhrman ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

When meeting the ex-wife’s new husband — her affair partner — what does he say? “Nice to meet you” won’t cut it.

The FDA has granted orphan drug designation (ODD) to Zai Lab’s ZL-1310, aimed at treating small cell lung cancer (SCLC).

Orphan 3 is given its most promising status update and reaction yet from Isabelle Fuhrman, who plays the eerie character Esther in the film.

A third installment in the Orphan horror film series is currently in the works at Lionsgate. Isabella Fuhrman, who played the psychopathic Esther in the first two movies, recently offered some insight ...

Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.

The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome ...